Discontinuation report RESCRIPTOR

Last updated on 2018-11-02 History
Report ID 9176
Drug Identification Number 02238348
Brand name RESCRIPTOR
Common or Proper name delavirdine mesylate tablet
Company Name VIIV HEALTHCARE ULC
Market Status CANCELLED POST MARKET
Active Ingredient(s) DELAVIRDINE MESYLATE
Strength(s) 100MG
Dosage form(s) TABLET
Route of administration ORAL
Packaging size 360s
ATC code J05AG
ATC description DIRECT ACTING ANTIVIRALS
Reason for discontinuation Raw material availability
Anticipated discontinuation date
Actual discontinuation date 2018-11-01
Remaining supply date 2019-04-30
Discontinuation status Discontinued
Discontinuation decision reversal No
Information on remaining supply
Company comments
Health Canada comments
Tier 3 Status No
Company contact information 1-877-393-8448

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v10 2018-11-02 English Compare
v9 2018-11-01 French Compare
v8 2018-11-01 English Compare
v7 2018-06-13 French Compare
v6 2018-06-13 English Compare
v5 2018-06-09 English Compare
v4 2018-06-08 French Compare
v3 2018-06-08 English Compare
v2 2017-05-05 French Compare
v1 2017-05-05 English Compare

Showing 1 to 10 of 10